Our Objectives

Our Objectives

LuCE aims to raise awareness about inequities regarding the access to lung cancer treatment and care in Europe. Moreover, it advocates European policies that will lead to improvements in lung cancer prevention, early detection, treatment and care.

Read More

Our Members

Our Members

Lung Cancer Europe provides a European platform for national lung cancer patient advocacy groups and supports the establishment of those groups in countries where such groups do not yet exist. Our member organisations and associate members come from all over Europe.

Read More

Our Diagnosis

Our Diagnosis

Lung cancer is literally the biggest cancer killer worldwide – causing more deaths than breast and prostate cancer put together all over the world. Read more about our diagnosis, types and stages of lung cancer, treatments and clinical trials, but also how to cope with lung cancer.

Read More

Open letter: Increasing the early diagnosis of lung cancer in Europe: an essential milestone to tackle the biggest cancer killer

Dear MEPs, The European Respiratory Society (ERS), together with the undersigned 27 organisations, urges you to take into account the importance of lung cancer early diagnosis in achieving the goals of the Europe’s Beating Cancer Plan while discussing the draft report which will be presented tomorrow in the BECA Committee. Read the open letter (pdf)

Read More

LuCE Webinar: Strenghtening the Lung Cancer Patient Voice in Health Policy and Regulatory Decision

As part of its Educational & Capacity Building Programme, Lung Cancer Europe (LuCE) ran an introductory session on Strengthening the Lung Cancer Patient Voice in Health Policy and Regulatory Decision Making.  During this session we explore different policy, regulatory and access decision making frameworks and discuss  the opportunities for  lung cancer patient representatives to have a strong voice in the various decision making […]

Read More

IASCL Language Guide

The International Association for the Study of Lung Cancer released its first-ever Language Guide to promote best practices in all written and spoken language for submitted abstracts and presentations at its conferences, as well as for all members of the lung cancer community. The guide is available for  download here. The Language Guide helps address the stigmatization that patients with […]

Read More

Investing in the future: Improving cancer biomarker testing and cancer diagnosis for sustainable healthcare

Investing in the future: Improving cancer biomarker testing and cancer diagnosis for sustainable healthcare is a new white paper co-authored by a team of medical and patient advocacy experts, including representatives from the ECPC, Oncohealth Institute and Fight Bladder Cancer. The white paper calls for increased access to cancer biomarker testing, to identify those who will benefit most from precision […]

Read More